Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
ONPH stock has risen by 11.90 K% compared to the previous week, the month change is a 59.90 K% rise, over the last year Oncology Pharma Inc. has showed a 64.71% decrease.
No, ONPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ONPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncology Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
ONPH reached its all-time high on Aug 16, 2013 with the price of 375000.0000 USD, and its all-time low was 0.000001 USD and was reached on Nov 8, 2023. See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncology Pharma Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncology Pharma Inc. stock shows the sell signal. See more of Oncology Pharma Inc. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.